Status:

WITHDRAWN

Virgin Coconut Oil Oral Supplementation for Leprosy Patients

Lead Sponsor:

Philippine Dermatological Society

Conditions:

Hansen's Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

To date, there has been no clinical investigation on the effects of virgin coconut oil (VCO) oral supplementation on patients with Hansen's disease (HD) undergoing medical treatment. This study aims t...

Detailed Description

Objective: To determine the effect of co-administration of virgin coconut oil (VCO) oral supplementation and standard Multi-Drug Therapy (MDT) on malondialdehyde (MDA), superoxide dismutase (SOD), and...

Eligibility Criteria

Inclusion

  • Patients aged 18 years and above, male or female
  • Patients with clinical evidence and histological confirmation of lepromatous leprosy (LL), borderline lepromatous leprosy (BL), borderline leprosy (BB), borderline tuberculoid leprosy (BT), or tuberculoid leprosy (TT) according to the Ridley and Jopling classification and Paucibacillary (PB) or Multibacillary (MB) disease based on the World Health Organization (WHO) classification
  • Patients should not have been on MDT in the past
  • Patients with normal blood test results for complete blood count (CBC), liver aminotransaminases (AST, ALT), glucose-6-phosphate dehydrogenase (G6PD) assay, creatinine, lipid profile and chest x-ray

Exclusion

  • HD patients with reactions needing prednisone therapy at time of diagnosis
  • Patients who are already taking VCO or any other oral or intravenous antioxidant supplements
  • Patients taking long term medications unrelated to leprosy
  • Pregnant women
  • Patients with history of smoking, co-infections such as tuberculosis, diabetes mellitus, any other systemic diseases or health problems
  • Patients not willing to return for follow-up

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2018

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01885611

Start Date

June 1 2013

End Date

June 1 2018

Last Update

April 5 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Philippine General Hospital

Manila, Manila, Philippines, 1000